Newsletter | July 1, 2026

07.01.26 -- Bridging Community And Central Hospitals With Japan's DCT Model

DECENTRALIZED TRIALS

Bridging Community And Central Hospitals With Japan's DCT Model

Guest Column | By Takuma Matsunaga, Japan

Regulatory support and improved DCT infrastructure, as well as a uniquely Japanese approach to site relationships, are advancing the DCT landscape in Japan, explains consultant Takuma Matsunaga.

Rethinking Lab Logistics: Delivering The Complex Without Compromise

Brochure | MRN - Medical Research Network

Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.

TRIAL MANAGEMENT

Where Are We With Clinical Trial Tokenization?

From The Editor | By Dan Schell, chief editor, Clinical Leader

In January 2024, I interviewed Tom Dougherty about a topic many clinical research professionals had heard mentioned, but few could confidently explain: tokenization. I wanted to get caught up on any progress that's been made, so I completed this Q&A with Dougherty, the Real-World Data Strategy Director at CMR - Clinical Data Science & Evidence at Novo Nordisk.

Scalable Logistics In The Era Of Dynamic Clinical Trials

Webinar | Thermo Fisher Scientific

Discover how to transform logistical challenges into strategic advantages with flexible, forward-looking solutions designed for today’s dynamic clinical development landscape.

Anticipate Operational Pitfalls And Reduce Protocol Amendments

White Paper | Advarra

This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

Neuroscience Showcase: From Chance Discovery To Molecular Biology

Webinar | Dr. Vince Clinical Research

From chance discoveries to targeted molecular therapies, this presentation examines how advances in neurobiology, genetics, and circuit-based understanding are transforming drug development.

GLP‑1 Clinical Trial Eye Safety: Semaglutide Eye Risks

Article | 20/20 Onsite

While GLP-1 receptor agonists offer significant health benefits, proactive eye care and vigilance are essential to mitigate the risk of irreversible ocular conditions.

Improving Compliance and Scale in Research Pharmacy Workflows

Brochure | McCreadie Group

Modernize research pharmacy operations with digital workflows that reduce manual effort, improve compliance, strengthen audit readiness, and help sites support more protocols with confidence.

De-Risk Randomization With The Endpoint Biostatistical Approach

Brochure | Endpoint Clinical

With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: